Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation

NCT07573111 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Leukemia
Myelodysplastic Syndrome

Interventions

BIOLOGICAL: QUAIL-100

Sponsor

Laguna Biotherapeutics, Inc.